selected publications
- Design and creation of a racially diverse lung cancer registry with detailed genomic and environmental annotation. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2025 Academic Article GET IT
- The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC. Journal of the National Cancer Institute. 2025 Academic Article GET IT
-
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancer.
The Journal of thoracic and cardiovascular surgery.
2025
Academic Article
GET IT
Times cited: 1 - Expanding the Clinical Phenotype of Autosomal Recessive Chronic Granulomatous Disease. Journal of clinical immunology. 2024 Letter GET IT
- Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted Indirect Comparisons. Clinical lung cancer. 2024 Academic Article GET IT
- Integrating Health Equity in the ASCO Guideline Agenda: Recommendations From Members of the Palliative Care Expert Panel. JCO oncology practice. 2024 Academic Article GET IT
- Top Ten Tips Palliative Care Clinicians Should Know About Caring for Filipino American and Korean American Patients. Journal of palliative medicine. 2023 Academic Article GET IT
-
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020
Comment
GET IT
Times cited: 105 -
Standardization of Inpatient CPR Status Discussions and Documentation Within the Division of Hematology-Oncology at UPMC Shadyside: Results From PDSA Cycles 1 and 2.
Journal of oncology practice.
2019
Academic Article
GET IT
Times cited: 2 -
Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1-Expressing Non-Small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2018
Article
GET IT
Times cited: 2 -
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica.
2018
Academic Article
GET IT
Times cited: 151 -
Discontinuation of Everolimus Due to Related and Unrelated Adverse Events in Cancer Patients: A Meta-Analysis.
Cancer investigation.
2017
Information Resource
GET IT
Times cited: 3 -
Atrial Myxoma: A Case Presentation and Review.
2012
GET IT
Times cited: 13 - Cavernous transformation of portal vein secondary to portal vein thrombosis: a case report. Journal of clinical medicine research. 2012 Academic Article GET IT
- Heparin induced thrombocytopenia: case presentation and review. Journal of clinical medicine research. 2012 Academic Article GET IT